Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer’s-like pathology
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
The proliferation and activation of microglial cells is a hallmark of several neurodegenerative conditions. This mechanism is regulated by the activation of the colony-stimulating factor 1 receptor (CSF1R), thus providing a target that may prevent the progression of conditions such as Alzheimer’s disease. However, the study of microglial proliferation in Alzheimer’s disease and validation of the efficacy of CSF1R-inhibiting strategies have not yet been reported. In this study we found increased proliferation of microglial cells in human Alzheimer’s disease, in line with an increased upregulation of the CSF1R-dependent pro-mitogenic cascade, correlating with disease severity. Using a transgenic model of Alzheimer’s-like pathology (APPswe, PSEN1dE9; APP/PS1 mice) we define a CSF1R-dependent progressive increase in microglial proliferation, in the proximity of amyloid-β plaques. Prolonged inhibition of CSF1R in APP/PS1 mice by an orally available tyrosine kinase inhibitor (GW2580) resulted in the blockade of microglial proliferation and the shifting of the microglial inflammatory profile to an anti-inflammatory phenotype. Pharmacological targeting of CSF1R in APP/PS1 mice resulted in an improved performance in memory and behavioural tasks and a prevention of synaptic degeneration, although these changes were not correlated with a change in the number of amyloid-β plaques. Our results provide the first proof of the efficacy of CSF1R inhibition in models of Alzheimer’s disease, and validate the application of a therapeutic strategy aimed at modifying CSF1R activation as a promising approach to tackle microglial activation and the progression of Alzheimer’s disease. Microglial proliferation and activation is a hallmark of Alzheimer’s disease. Olmos-Alonso et al. show that microglial proliferation in Alzheimer’s disease tissue correlates with overactivation of the colony-stimulating factor 1 receptor (CSF1R) pathway. CSF1R blockade arrests microglial proliferation and activation in a mouse model of Alzheimer-like pathology and slows disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The absence of microglia did not significantly alter the levels of Aβ38, Aβ40, or Aβ42, in detergent-soluble or -insoluble cortical and thalamic homogenates in either the 4- or 7- month cohorts (Fig. 5a–h), in line with multiple studies showing that CSF1R inhibition does not affect Aβ production/clearance10,27,28.”
From Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer’s disease model (2019) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Targeting CSF-1R has recently been reported to ameliorate AD pathology in APP/PS1 mice, where inhibition of CSF-1R reduced microglial proliferation and decreased the inflammatory phenotype of microglia around amyloid plaques [35].”
From Loss of homeostatic microglial phenotype in CSF1R-related Leukoencephalopathy (2020) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Microglial proliferation has been shown to be the main contributor to increased microglial numbers under certain disease states such as ischemia, facial nerve transection, prion disease, and Alzheimer’s disease [42, 61–64].”
From IL-1β-driven amyloid plaque clearance is associated with an expansion of transcriptionally reprogrammed microglia (2019) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While the use of these agents is limited in experimental TBI studies, several groups have reported that microglial elimination [via colony-stimulating factor 1 receptor (CSF1R) inhibition] improves behavioral performance and synaptic functioning independent of Aβ accumulation in multiple transgenic mouse models of AD (3xTg, 5xFAD, APP/PS1) (236–238).”
From The Inflammatory Continuum of Traumatic Brain Injury and Alzheimer’s Disease (2018) · cites this paper as [237]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“activated microglia in AD show increased proliferation (63,64) and increased expression of inflammatory markers such as CD36, CD14, CD11c, MHC-II, and iNOS (65,66)”
From Microglia in Alzheimer's disease (2017) · cites this paper as [64]
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020 · cited 5×
“…pathogenesis is supported by recent genome-wide association studies, highlighting immune-related genes such as CR1 (Jun et al., 2010), TREM2 (Guerreiro et al., 2013; Jonsson et al., 2013) or HLA-DRB5–HLA-DRB1 in association with Alzheimer’s disease (European Alzheimer’s Disease et al.,…”
ResultInfluentialVariant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558 · cited 5×
“The contribution of inflammation to disease pathogenesis is supported by recent genome-wide association studies, highlighting immune-related genes such as CR1 (Jun et al., 2010), TREM2 (Guerreiro et al., 2013; Jonsson et al., 2013) or HLA-DRB5–HLA-DRB1 in association with Alzheimer’s disease (European Alzheimer’s Dise…”
InfluentialCSF-1R inhibition alters macrophage polarization and blocks glioma progression
Pyonteck, S. M., Akkari, L., Schuhmacher, A. J., Bowman, R. L., Sevenich, L., Quail, D. F., Olson, O. C., Quick, M. L., Huse, J. T., Teijeiro, V., et al. (2013) · Nature Medicine · doi:10.1038/nm.3337 · Cited by 2,463 · cited 2×
“The therapeutic potential of CSF1R inhibitors has been suggested in inflammatory diseases, autoimmune dis- orders, bone disease and cancer (Burns and Wilks, 2011; Pyonteck et al., 2013).”
BackgroundMethodNelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050 · cited 4×
“, 2009), together with tangle pathology (Nelson et al., 2012) or neurodegeneration-related biomarkers (Wirth et al.”
BackgroundInfluentialElmore, M. R. P., Najafi, A. R., Koike, M. A., Dagher, N. N., Spangenberg, E. E., Rice, R. A., Kitazawa, M., Matusow, B., Nguyen, H., West, B. L., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.040 · Cited by 1,968
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657 · cited 1×
“Activated microglia have been demonstrated in transgenic models of Alzheimer’s disease (LaFerla and Oddo, 2005; Jucker, 2010) and have been recently shown to dominate the gene expression landscape of patients with Alzheimer’s disease (Zhang et al., 2013).”
BackgroundMicroglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543 · cited 2×
“microglia with an activated phenotype (Perry et al., 2010)”
BackgroundSelf-citation
Cited by
Items 301–400 of 533
Cao, P., Cheng, Y., Li, Z., Cheng, Y., Chu, X., Geng, C., Yin, X., & Li, Y. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01794-6 · Cited by 15
The Influence of the Gut Microbiota on Alzheimer's Disease: A Narrative Review
Yin, J.-T., Xu, X., Jin, C.-Y., Yuan, X., & Wang, X. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2202038 · Cited by 15
Strategies to dissect microglia-synaptic interactions during aging and in Alzheimer's disease
Heuer, S. E., Bloss, E. B., & Howell, G. R. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109987 · Cited by 16
Therapeutic Targets in Innate Immunity to Tackle Alzheimer’s Disease
Serradas, M. L., Ding, Y., Martorell, P., Kulińska, I., & Castro‐Gomez, S. (2024) · Cells · doi:10.3390/cells13171426 · Cited by 17
Klein, H., Schäfer, M. K.-H., Bennett, D. A., Schwender, H. R., & Jager, P. L. D. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007771 · Cited by 17
Qiu, Z., Bai, X., Ji, X., Wang, X., Han, X., Wang, D., Jiang, F., & An, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.960906 · Cited by 16
Mancini, V. S. B. W., Pietro, A. A. D., de Olmos, S., Pinto, P. S., Vence, M., Marder, M., Igaz, L. M., Marcora, M. S., Pasquini, J. M., Correale, J. D., et al. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15566 · Cited by 16
Topalis, V., Voros, C., & Ziaka, M. (2025) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887251361578 · Cited by 16
Henningfield, C. M., Soni, N., Lee, R. W., Sharma, R. B., Cleland, J. L., & Green, K. N. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01470-3 · Cited by 19
Role of NLRP3 Inflammasome in Chronic Pain and Alzheimer's Disease—A Review
Moradi, F., & Mokhtari, T. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70071 · Cited by 18
Dongre, P., Ramesh, M., Govindaraju, T., & Inamdar, M. S. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03415-5 · Cited by 14
Romero‐Molina, C., Navarro, V., Jiménez, S., Muñoz‐Castro, C., Sanchez-Mico, M. V., Gutiérrez, A., Vitórica, J., & Vizuete, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189734 · Cited by 16
Torii, K., Takagi, S., YOSHIMURA, R., & Miyata, S. (2022) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2022.577832 · Cited by 14
Discovery of acyl ureas as highly selective small molecule CSF1R kinase inhibitors
Caldwell, T. M., Kaufman, M. D., Wise, S., Ahn, Y. M., Hood, M. M., Lu, W.-P., Patt, W. C., Samarakoon, T. B., Vogeti, L., Vogeti, S., et al. (2022) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2022.128929 · Cited by 14
Yousefizadeh, A., Piccioni, G., Saidi, A., Triaca, V., Mango, D., & Nisticò, R. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106404 · Cited by 16
Multitasking Microglia and Alzheimer’s Disease: Diversity, Tools and Therapeutic Targets
Grubman, A., Kanninen, K. M., & Malm, T. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0825-5 · Cited by 16
Cranial irradiation acutely and persistently impairs injury-induced microglial proliferation
Belcher, E. K., Sweet, T. B., Karaahmet, B., Dionisio-Santos, D. A., Owlett, L. D., Leffler, K. A., Janelsins, M. C., Williams, J. P., Olschowka, J. A., & O’Banion, M. K. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100057 · Cited by 16
NLRX1 mediated impaired microglial phagocytosis of NETs in cerebral ischemia and reperfusion injury
Peng, J., Huang, Y., He, T., Zhan, Y., & Liu, J. (2025) · Cell Death and Differentiation · doi:10.1038/s41418-025-01526-3 · Cited by 16
Perspectives on Alzheimer’s Disease Treatment Based on Counteracting Oxidative Stress
Bilski, R., Dąbkowski, S., Kozieł, I., Kozicki, M., Małachowska, A., Przygocki, M., & Tyska, O. (2025) · Biomolecules · doi:10.3390/biom15091345 · Cited by 13
Yuan, K., Wu, Q., Yao, Y., Shao, J., Zhu, S., Yang, J., Sun, Q. L., Zhao, J., Xu, J., Wu, P., et al. (2024) · Translational Stroke Research · doi:10.1007/s12975-024-01282-5 · Cited by 13
Piccioni, G., Maisto, N., d’Ettorre, A., Strimpakos, G., Nisticò, R., Triaca, V., & Mango, D. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03019-2 · Cited by 17
Don’t know what you got till it’s gone: microglial depletion and neurodegeneration
Graykowski, D. R., & Cudaback, E. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.308078 · Cited by 14
Wang, W., Sun, W., Gao, X., Peng, L., Lin, L., Xiao, K., Liu, Y., Di, X., Zhu, S., Chen, H., et al. (2022) · Neurourology and Urodynamics · doi:10.1002/nau.24896 · Cited by 12
Immunosenescence of brain accelerates Alzheimer’s disease progression
Chen, H.-Y., Zhao, Y. G., & Xie, Y. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0021 · Cited by 12
The Strategies for Treating “Alzheimer’s Disease”: Insulin Signaling May Be a Feasible Target
You, G., Yao, J., Liu, Q., & Li, N. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44120421 · Cited by 12
Best Medicine for Dementia: The Life-Long Defense of the Brain
Andersson, M. J., & Stone, J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230429 · Cited by 14
Stevenson, W., Hase, Y., Wilson, E., Hollins, A., Hase, M., Ennaceur, A., Craggs, L., Ihara, M., Horsburgh, K. J., & Kalaria, R. N. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.07.014 · Cited by 13
Genetic variability in response to Aβ deposition influences Alzheimer’s risk
Salih, D. A., Bayram, S., Guelfi, M. S., Reynolds, R., Shoai, M., Ryten, M., Brenton, J., Zhang, D., Matarin, M., Botia, J., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/437657 · Cited by 12
Krbot, K., Hermann, P., Skorić, M. K., Zerr, I., Sepulveda‐Falla, D., Goebel, S., Matschke, J., Krasemann, S., & Glatzel, M. (2018) · Neuropathology · doi:10.1111/neup.12517 · Cited by 11
“Recent studies in murine models suggest that microgliosis in AD and prion diseases is mainly caused by local proliferation of resident microglial cells, with minimal or no recruitment of MDM.(20,22,42) Microglial activation is more pronounced in sCJD when compared to AD.”
BackgroundResultInfluentialGao, J., Zhang, H., Zhou, L., Liu, J., Zhuo, E., Shen, Y., Liu, X., & Shen, Q. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03792-z · Cited by 13
CSF1R inhibition depletes brain macrophages and reduces brain virus burden in SIV-infected macaques
Bohannon, D. G., Zablocki-Thomas, L., Leung, E. S., Dupont, J. K., Hattler, J. B., Kowalewska, J., Zhao, M., Luo, J., Salemi, M., Amedee, A. M., et al. (2024) · Brain · doi:10.1093/brain/awae153 · Cited by 11
Amyloid-β-activated microglia can induce compound proteinopathies
Lee, S. H., Bae, E.-J., Pérez-Acuña, D., Jung, M. K., Han, J. W., Mook‐Jung, I., & Lee, S. (2024) · Brain · doi:10.1093/brain/awae221 · Cited by 12
The role of microglia in the prion-like transmission of protein aggregates in neurodegeneration
Öztürk, M. M., Emgård, J., García‐Revilla, J., Fernández‐Calle, R., Yang, Y., Deierborg, T., & Roos, T. T. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf087 · Cited by 17
Jiao, H., Ge, Y., Huang, L.-Y., Liu, Y., Wu, B., Lian, P., Hao, Y., Han, S., Li, Y., Wu, K., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00887-0 · Cited by 14
Microglia in Alzheimer’s Disease: A Favorable Cellular Target to Ameliorate Alzheimer’s Pathogenesis
Sumsuzzman, D. M., Uddin, M. S., Kabir, M. T., Hasana, S., Perveen, A., Alanazi, I. S., Albadrani, G. M., Abdel‐Daim, M. M., & Ashraf, G. M. (2022) · Mediators of Inflammation · doi:10.1155/2022/6052932 · Cited by 12
Irastorza, I. T., Río, I. B., Puente, N., Serrano, M., Mimenza, A., Lekunberri, L., Lusar, I. A., Reguero, L., Gerrikagoitia, I., Esteban, S. R. D. M., et al. (2022) · Glia · doi:10.1002/glia.24312 · Cited by 12
Aarhus, T. I., Teksum, V., Unger, A., Habenberger, P., Wolf, A., Eickhoff, J., Klebl, B., Wolowczyk, C., Bjørkøy, G., Sundby, E., et al. (2023) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202300052 · Cited by 11
Ricciardi, N. R., Modarresi, F., Lohse, I., Andrade, N. S., Newman, I. A., Brown, J. M., Borja, C., Marples, B., Wahlestedt, C., & Volmar, C. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03373-0 · Cited by 12
Pharmacology of Berberine and Its Metabolites, Is It the Natures Ozempic or Imatinib?
Singh, N. K., Dhanasekaran, M., & Kumar, A. H. S. (2023) · Archives of Pharmacology and Therapeutics · doi:10.33696/pharmacol.4.046 · Cited by 12
Rushworth, J. L., Montgomery, K. S., Cao, B., Brown, R., Dibb, N. J., Nilsson, S. K., Chiefari, J., & Fuchter, M. J. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00529 · Cited by 11
Poulen, G., Bartolami, S., Noristani, H. N., Perrin, F. E., & Gerber, Y. N. (2021) · Brain Sciences · doi:10.3390/brainsci11121643 · Cited by 12
Kang, Y., Toyoda, H., & Saito, M. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1425645 · Cited by 10
Xu, B., Tang, C., Han, R., Zhu, C., Yang, Y., Li, H. J., Wu, N., & He, D. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251326044 · Cited by 14
Neuroinflammation als Motor der Alzheimer-Erkrankung
Castro‐Gomez, S., Binder, J., & Heneka, M. T. (2019) · Der Nervenarzt · doi:10.1007/s00115-019-0778-3 · Cited by 17
Genetic dependency of Alzheimer’s disease-associated genes across cells and tissue types
Jaladanki, S. K., Elmas, A., Malavé, G. S., & Huang, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-91713-2 · Cited by 15
Verkhratsky, A., & Butt, A. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821565-4.00012-2 · Cited by 10
Meraz‐Ríos, M. A., Rochín-Hernández, L. J., Ramírez-Reyes, L., Figueroa‐Corona, M. D. P., Sánchez-González, V., Orozco-Barajas, M., & Jiménez-Acosta, M. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612606 · Cited by 11
Liu, J., Zhang, X., Xu, Y., & Zhang, S. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03557-8 · Cited by 11
Monitoring the Response of Hyperbilirubinemia in the Mouse Brain by In Vivo Bioluminescence Imaging
Manni, I., Rocco, G. D., Fusco, S., Leone, L., Barbati, S. A., Carapella, C. M., Grassi, C., Piaggio, G., & Toietta, G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms18010050 · Cited by 10
Headmasters: Microglial regulation of learning and memory in health and disease
Weinhard, L., d’Errico, P., & Tay, T. L. (2018) · AIMS molecular science · doi:10.3934/molsci.2018.1.63 · Cited by 12
Ramadurgum, P., Woodard, D. R., Daniel, S., Peng, H., Mallipeddi, P. L., Niederstrasser, H., Mihelakis, M., Chau, V. Q., Douglas, P. M., Posner, B. A., et al. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.03.006 · Cited by 10
Wickstead, E. S., Irving, M. A., Getting, S. J., & McArthur, S. (2021) · FEBS Journal · doi:10.1111/febs.15861 · Cited by 11
Microglia and major depression: not yet a clear picture
Perry, V. H. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30087-7 · Cited by 11
Self-citationCheng, F., Wang, C., Yan, B., Yin, Z., Liu, Y., Zhang, L., Li, M., Liao, P., Gao, H., Jia, Z., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112071 · Cited by 9
Involvement of IL-10R/STAT3 pathway in amyloid β clearance by microlgia in Alzheimer's disease
Liu, H., Zhou, Y., & Song, W. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108263 · Cited by 17
Cheung, S. K. K., Kwok, J., Or, P. M. Y., Wong, C. W., Feng, B., Choy, K. W., Chang, R. C., Burbach, J. P. H., Cheng, A. S. L., & Chan, A. M.-L. (2023) · Scientific Reports · doi:10.1038/s41598-023-33869-7 · Cited by 9
Repositioning of receptor tyrosine kinase inhibitors
Mansour, H. M., & El-Khatib, A. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18677-6.00010-5 · Cited by 13
Glial cells as a promising therapeutic target of glaucoma: beyond the IOP
Shinozaki, Y., Namekata, K., Guo, X., & Harada, T. (2024) · Frontiers in Ophthalmology · doi:10.3389/fopht.2023.1310226 · Cited by 9
Potential Alzheimer’s disease drug targets identified through microglial biology research
Lepiarz‐Raba, I., Hidayat, T., Hannan, A. J., & Jawaid, A. (2024) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2335210 · Cited by 10
Stable biomarker for plastic microglia
Segal, B. M., & Giger, R. J. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601669113 · Cited by 10
PET Imaging of Neuroinflammation
Chaney, A. M., Deal, E. M., Jackson, I. M., & James, M. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816386-3.00047-8 · Cited by 11
Presymptomatic change in microRNAs modulates Tau pathology
Sharma, S., Khadimallah, I., Corya, A. W., Ali, Y., Rao, X., Liu, Y., & Lu, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-27527-6 · Cited by 10
Fukushima, S., Kurganov, E., Hiratsuka, D., & Miyata, S. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00079-1 · Cited by 9
Kikhia, M., Schilling, S., Herzog, M., Livne, M., Semtner, M., Tay, T. L., Prinz, M., Kettenmann, H., Endres, M., Kronenberg, G., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63949-3 · Cited by 11
CSF1R inhibition at chronic stage after spinal cord injury modulates microglia proliferation
Perez, J., Poulen, G., Cardoso, M., Boukhaddaoui, H., Gazard, C., Courtand, G., Bertrand, S. S., Gerber, Y. N., & Perrin, F. E. (2023) · Glia · doi:10.1002/glia.24451 · Cited by 10
c-KIT inhibitors reduce pathology and improve behavior in the Tg(SwDI) model of Alzheimer’s disease
Stevenson, M. E., Hebron, M. L., Liu, X., Balaraman, K., Wolf, C., & Moussa, C. (2024) · Life Science Alliance · doi:10.26508/lsa.202402625 · Cited by 9
Targeting colony stimulating factor-1 receptor signalling to treat ectopic pregnancy
Ahmad, S. F., Duncan, W. C., Campbell, L. L., Beaty, R. E., Koscielniak, M., Collins, F., Saunders, P. T. K., & Horne, A. W. (2020) · Scientific Reports · doi:10.1038/s41598-020-72785-y · Cited by 8
MR spectroscopy in Alzheimer’s disease
Sheikh‐Bahaei, N. (2020) · Biomedical Spectroscopy and Imaging · doi:10.3233/bsi-200194 · Cited by 9
Modulating Microglial Cells for Promoting Brain Recovery and Repair
Hermann, D. M., & Gunzer, M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.627987 · Cited by 9
Grubman, A., Choo, X. Y., Chew, G., Ouyang, J. F., Sun, G., Croft, N. P., Rossello, F. J., Simmons, R., Buckberry, S., Landin, D. V., et al. (2019) · doi:10.1101/639054 · Cited by 7
Soluble CSF1R promotes microglial activation and amyloid clearance in Alzheimer’s disease
Zhang, L., Chen, K., Zeng, R., Bu, G., & Chen, X.-F. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03558-5 · Cited by 7
Gallo, C., Verrillo, L., Manzo, E., Cauzzi, E., Barbera, L. L., Sabatino, G., Paolis, M. L. D., Sciacca, M. F. M., Barra, G., Peroni, E., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03634-w · Cited by 10
Singh, A. S., Naqvi, A. R., & Chanu, M. T. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.01.050 · Cited by 7
Attack of the Clones: Microglia in Health and Disease
Manjally, A. V., & Tay, T. L. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.831747 · Cited by 8
Endothelial senescence alleviates cognitive impairment in a mouse model of Alzheimer 's disease
Horibe, S., Emoto, T., Mizoguchi, T., Tanaka, T., Kawauchi, S., Sasaki, N., Yamashita, T., Ikeda, K., Emoto, N., Hirata, K., et al. (2023) · Glia · doi:10.1002/glia.24461 · Cited by 11
Adhikari, A., Chauhan, K., Adhikari, M., & Tiwari, A. K. (2024) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.117628 · Cited by 7
Pyrrolopyrimidine based CSF1R inhibitors: Attempted departure from Flatland
Bjørnstad, F., Havik, S., Aarhus, T. I., Mahdi, I., Unger, A., Habenberger, P., Degenhart, C., Eickhoff, J., Klebl, B., Sundby, E., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.116053 · Cited by 7
Hoeijmakers, L., Meerhoff, G. F., de Vries, J. W., Ruigrok, S. R., van Dam, A., LEUVEN, F. V., Kőrösi, A., & Lucassen, P. J. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.09.013 · Cited by 7
Dysregulated Microglial Cell Activation and Proliferation Following Repeated Antigen Stimulation
Prasad, S., Sheng, W. S., Hu, S., Chauhan, P., & Lokensgard, J. R. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.686340 · Cited by 7
Imaging of Microglial Activation in Alzheimer’s Disease by [11C]PBR28 PET
Donat, C. K., Mirzaei, N., Tang, S.-P., Edison, P., & Sastre, M. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7704-8_22 · Cited by 8
Zhu, Q., Song, Y., Qian, Y., Zhang, R., Xue, J., & Hou, Y. (2025) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2025.25 · Cited by 10
Zong, L., Chen, P., Shi, J., Chen, H., Lin, W., Ou, G., & Chen, X. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1695058 · Cited by 6
Moving towards a more realistic concept of what constitutes Alzheimer's disease
Hölscher, C. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.030 · Cited by 7
The Role of Tau Protein in Diseases
Das Bhaskar, C. (2018) · Annals of Advances in Chemistry · doi:10.29328/journal.aac.1001010 · Cited by 10
Long, I. (2025) · Biomedical Research and Therapy · doi:10.15419/s00m4g68 · Cited by 7
A radioligand for in vitro autoradiography of CSF1R in post-mortem CNS tissues
Foss, C. A., Naik, R., Das, D., Cha, H., Minn, I., Hall, A., Finley, P. A., Wu, S. J., Du, Y., Dannals, R. F., et al. (2024) · EJNMMI Research · doi:10.1186/s13550-024-01133-2 · Cited by 6
Borjini, N., Fernández, M., Giardino, L., Sorokin, L. M., & Calzà, L. (2025) · Cells · doi:10.3390/cells14060414 · Cited by 6
Wu, J., Zhang, J., & Lin, B. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03525-0 · Cited by 6
Shen, L., Chen, D., Lou, Q., Cao, P., Hu, R. M., Jin, Y., Wang, D., & Hu, S.-S. (2022) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-022-10054-7 · Cited by 5
The latest perspectives of small molecules FMS kinase inhibitors
Alkubaisi, B. O., Aljobowry, R., Ali, S. M., Sultan, S., Zaraei, S., Ravi, A., Al‐Tel, T. H., & El-Gamal, M. I. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115796 · Cited by 5
Radiolabeled imaging agents for Alzheimer's disease
Wu, J., Li, K., Yang, J., Mao, M., & Cheng, Y. (2023) · iRadiology · doi:10.1002/ird3.35 · Cited by 5
Potential role of Drug Repositioning Strategy (DRS) for management of tauopathy
Zaki, M. O., Elsherbiny, D. A., Salama, M., & Azab, S. S. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120267 · Cited by 7
Microglia depletion prevents lactation by inhibition of prolactin secretion
Csikós, V., Oláh, S., Dóra, F., Arrasz, N., Cservenák, M., & Dobolyi, Á. (2023) · iScience · doi:10.1016/j.isci.2023.106264 · Cited by 5
Blocking microglial proliferation halts Alzheimer disease in mice
Fyfe, I. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.6 · Cited by 5
Chen, Y., Wang, T., Rogers, K. A., Rutt, B. K., & Ronald, J. A. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180714 · Cited by 5
Neurogliovascular alterations in brain pathologies across lifespan
Daigle, B., Bevilacqua, L. M., Noël, V. P., Lebel, M., Côté, D. C., Lévesque, L., & Ménard, C. (2024) · Glial health research. · doi:10.1016/j.ghres.2024.100004 · Cited by 4
Chouhan, J. K., Fowler, S. B., Webster, C. I., & Teeling, J. L. (2017) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2018.10.004 · Cited by 5
Hu, Y., Wang, X., Zhao, Z., Liu, M., Ren, X., Xian, X., Liu, C., & Wang, Q. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240118 · Cited by 5
Beckers, L., Stroobants, S., Verheijden, S., West, B. L., D’Hooge, R., & Baes, M. I. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.03.004 · Cited by 4
Temporal dynamics of a CSF1R signaling gene regulatory network involved in epilepsy
Gérard, C., Mot, L. D., Cordi, S., van Eyll, J. M., & Lemaigre, F. P. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008854 · Cited by 6
Metadata
- Authors
- Olmos-Alonso, A., Schetters, S. T. T., Sri, S., Askew, K., Mancuso, R., Vargas-Caballero, M., Holscher, C., Perry, V. H., & Gomez-Nicola, D.
- Affiliations
- University of Southampton (GB)
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-01-08
- Volume
- 139
- Issue
- 3
- Pages
- 891-907
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC4766375
- OpenAlex
- W2222356562
- Cited by
- 532
- References
- 66
- Citations by year
- 2026: 38 · 2025: 50 · 2024: 50 · 2023: 57 · 2022: 45 · 2021: 79 · 2020: 51 · 2019: 44 · 2018: 51 · 2017: 37 · 2016: 30
- FWCI
- 29.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Brain (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- Lancaster EPrints (Lancaster University) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Alzheimer's Society
- Medical Research Council (MR/K022687/1)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- CSF1R inhibition, microglial proliferation, Alzheimer's disease, GW2580, tyrosine kinase inhibitors, APP/PS1 mice, amyloid plaques, microglial activation, anti-inflammatory phenotype, synaptic degeneration, memory impairment, neuroinflammation, disease progression
- MeSH terms
- Alzheimer Disease, Animals, Anisoles, Female, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Pyrimidines, Receptors, Granulocyte-Macrophage Colony-Stimulating Factor, Drug Delivery Systems, Microglia, Disease Progression, Protein Kinase Inhibitors, Cell Proliferation, Mice, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.